CorMedix

CRMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$606.407 M

$7.78 +0.13%

Close of 22 Sept 2026

Revenue

$311.7M

#2113 by revenue

Earnings

$163.1M

#1089 by earnings

Shares outstanding

77,944,324

Latest filing cover page

P/E ratio

3.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#195OculisOCS$621.0M
#196Crescent BiopharmaCBIO$610.6M
#197CorMedixCRMD$606.4M
#198Bright Minds BiosciencesDRUG$598.5M
#199Silence TherapeuticsSLN$575.2M

What if CorMedix were worth as much as…

Open the what-if tool →

Gold $30.2T

$387,891.87

Per share 49,858× higher

Bitcoin $1.74T

$22,344.86

Per share 2,872× higher

Nvidia $5.52T

$70,765.47

Per share 9,096× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for CorMedix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.